


default search action
"In-silico rituximab protein engineering to improve humanisation and ..."
Harit Kasana, Harish Chander, Ashwani Mathur (2024)
- Harit Kasana, Harish Chander, Ashwani Mathur:
In-silico rituximab protein engineering to improve humanisation and reduce immunogenicity. Int. J. Bioinform. Res. Appl. 20(2): 142-160 (2024)

manage site settings
To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.